123 related articles for article (PubMed ID: 37336272)
1. Prognostic and immunological role of Asporin across cancers and exploration in bladder cancer.
Wei F; Li T; Li J; Zhang Y; Liu T; Zhao Z; Zhu W; Guo H; Yang R
Gene; 2023 Aug; 878():147573. PubMed ID: 37336272
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma.
Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y
PeerJ; 2023; 11():e15284. PubMed ID: 37123010
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
Front Immunol; 2023; 14():955949. PubMed ID: 37006317
[TBL] [Abstract][Full Text] [Related]
4. miR-628-5p is a Potential Novel Prognosis Biomarker, Associated with Immune Infiltration in Bladder Urothelial Carcinoma.
Huang H; Xu Q; Zhang Y; Zhou Y; Ma K; Luo Y
Curr Pharm Des; 2023; 29(31):2477-2488. PubMed ID: 37916623
[TBL] [Abstract][Full Text] [Related]
5. Pancancer Analysis of the Oncogenic and Prognostic Role of
Liu Q; Xie R; Li Y
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077008
[TBL] [Abstract][Full Text] [Related]
6. TUBA1C is a potential new prognostic biomarker and promotes bladder urothelial carcinoma progression by regulating the cell cycle.
Jiang Y; Zhu C; Huang H; Huang G; Fu B; Xi X
BMC Cancer; 2023 Aug; 23(1):716. PubMed ID: 37528357
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of PLAU indicates its potential prognostic value and correlation with neutrophil infiltration in BLCA.
Shi K; Zhou J; Li M; Yan W; Zhang J; Zhang X; Jiang L
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166965. PubMed ID: 38000776
[TBL] [Abstract][Full Text] [Related]
8. PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma.
Li P; Qiao G; Lu J; Ji W; Gao C; Qi F
Math Biosci Eng; 2022 Jan; 19(1):169-190. PubMed ID: 34902986
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Investigation of Genes Associated with Cell Cycle Pathways for Prognosis and Immunotherapy in Bladder Urothelial Carcinoma.
Mi Y; Wang X
J Environ Pathol Toxicol Oncol; 2022; 41(3):1-12. PubMed ID: 35993952
[TBL] [Abstract][Full Text] [Related]
10. Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress.
Sasaki Y; Takagane K; Konno T; Itoh G; Kuriyama S; Yanagihara K; Yashiro M; Yamada S; Murakami S; Tanaka M
Cancer Sci; 2021 Mar; 112(3):1251-1261. PubMed ID: 33393151
[TBL] [Abstract][Full Text] [Related]
11. PRR11 is a prognostic biomarker and correlates with immune infiltrates in bladder urothelial carcinoma.
Ni W; Yi L; Dong X; Cao M; Zheng J; Wei Q; Yuan C
Sci Rep; 2023 Feb; 13(1):2051. PubMed ID: 36739300
[TBL] [Abstract][Full Text] [Related]
12. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
13. MTHFD2 is a potential oncogene for its strong association with poor prognosis and high level of immune infiltrates in urothelial carcinomas of bladder.
Zhu L; Liu X; Zhang W; Hu H; Wang Q; Xu K
BMC Cancer; 2022 May; 22(1):556. PubMed ID: 35581573
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic Asporin promotes cell migration by regulating TGF-β/Smad2/3 pathway and indicates a poor prognosis in colorectal cancer.
Li H; Zhang Z; Chen L; Sun X; Zhao Y; Guo Q; Zhu S; Li P; Min L; Zhang S
Cell Death Dis; 2019 Feb; 10(2):109. PubMed ID: 30728352
[TBL] [Abstract][Full Text] [Related]
15. ASPN Is a Potential Biomarker and Associated with Immune Infiltration in Endometriosis.
Wang L; Sun J
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011263
[TBL] [Abstract][Full Text] [Related]
16. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer.
Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B
J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts and the related Runt-related transcription factor 2 (RUNX2) promote bladder cancer progression.
Liu B; Pan S; Liu J; Kong C
Gene; 2021 Apr; 775():145451. PubMed ID: 33482279
[TBL] [Abstract][Full Text] [Related]
18. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
19. Identification of
Zhou R; Peng N; Li W
Front Immunol; 2022; 13():975503. PubMed ID: 36072584
[TBL] [Abstract][Full Text] [Related]
20. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C
DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]